Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia | Zendy

Min Zhong | Zendy; Julan Peng | Zendy; Lanhua Xiang | Zendy; Xinhuang Yang | Zendy; Xianghua Wang | Zendy; Yanbin Zhu | Zendy

Open Access

Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia

Author(s) -

Min Zhong,

Julan Peng,

Lanhua Xiang,

Xinhuang Yang,

Xianghua Wang,

Yanbin Zhu

Publication year - 2020

Publication title -

medical science monitor

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.636

H-Index - 85

eISSN - 1643-3750

pISSN - 1234-1010

DOI - 10.12659/msm.926924

Subject(s) - viability assay , hmgb1 , endothelial dysfunction , preeclampsia , umbilical vein , trophoblast , endothelial stem cell , downregulation and upregulation , angiogenesis , hypoxia (environmental) , cancer research , cell , biology , pharmacology , andrology , medicine , chemistry , in vitro , immunology , placenta , endocrinology , biochemistry , pregnancy , fetus , inflammation , genetics , organic chemistry , oxygen , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research